[Myelodysplastic syndrome with Th-polyagglutination]. 1986

Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D001789 Blood Group Antigens Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties. Blood Group,Blood Group Antigen,Blood Groups,Antigen, Blood Group,Antigens, Blood Group,Group Antigen, Blood,Group, Blood,Groups, Blood
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D004903 Erythrocyte Aggregation The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation. Erythrocyte Aggregation, Intravascular,Agglutination, Intravascular,Intravascular Agglutination,Intravascular Erythrocyte Aggregation,Rouleaux Formation, Erythrocyte,Agglutinations, Intravascular,Aggregation, Erythrocyte,Aggregation, Intravascular Erythrocyte,Aggregations, Erythrocyte,Aggregations, Intravascular Erythrocyte,Erythrocyte Aggregations,Erythrocyte Aggregations, Intravascular,Erythrocyte Rouleaux Formation,Erythrocyte Rouleaux Formations,Formation, Erythrocyte Rouleaux,Formations, Erythrocyte Rouleaux,Intravascular Agglutinations,Intravascular Erythrocyte Aggregations,Rouleaux Formations, Erythrocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
August 1978, Lancet (London, England),
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
June 1978, Lancet (London, England),
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
January 1989, Vox sanguinis,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
January 1982, Transfusion,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
October 1990, American journal of hematology,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
January 1983, Transfusion,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
December 1986, Harefuah,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
March 1976, Revue francaise de transfusion et immuno-hematologie,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
January 1992, Immunohematology,
Y Akahonai, and A Tanimura, and N Nakagawa, and M Mori, and K Kawasaki, and T Kobayashi, and A Yachi, and Y Ishii
January 1971, Nouvelle revue francaise d'hematologie,
Copied contents to your clipboard!